Myelodysplastic Syndrome (MDS) 1 protocols meet the specified criteriaOCR40609ACCESS: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies